Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...
No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...
Primary biliary cholangitis (PBC) has typically been considered a rare condition, with a pooled global estimated incidence of ...
Liver complications related to MASLD continue to increase around the world, particularly in economically disadvantaged countries.
Health on MSN23h
What To Know About Alanine Aminotransferase (ALT)Medically reviewed by Oliver Eng, MD Alanine aminotransferase (ALT) is an enzyme primarily found in your liver. An enzyme is ...
Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Rates ...
Virtual and in-person event, Bridging Basic Science and Liver Disease, brings together hundreds of leading biomedical ...
REL-P11 is a proprietary, low-dose, modified-release psilocybin formulationSingle-Ascending Dosing (SAD) study to evaluate safety and ...
HCC risk prediction may be poorly reported and biased for individuals with nonviral chronic liver disease.
Diabetes and obesity are intertwined health conditions with serious consequences if left unmanaged. Obesity increases the ...
New research shows that heavy alcohol use among adults in the U.S. has persisted beyond the pandemic. In 2022, heavy alcohol ...
New research suggests that stress hormones, rather than impaired insulin signaling, may primarily drive diabetes in obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback